Učitavanje...
Dissecting the Multiple Myeloma-bone microenvironment reveals new therapeutic opportunities
Multiple myeloma is a plasma cell skeletal malignancy. While therapeutic agents such as bortezomib and lenalidomide have significantly improved overall survival, the disease is currently incurable with the emergence of drug resistance limiting the efficacy of chemotherapeutic strategies. Failure to...
Spremljeno u:
| Izdano u: | J Mol Med (Berl) |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707075/ https://ncbi.nlm.nih.gov/pubmed/26423531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-015-1345-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|